|
Market Closed -
Euronext Paris
12:55:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.6280 EUR | -3.24% |
|
+13.56% | -9.51% |
| 10-27 | Valbiotis expands onto Amazon France, TP ICAP Midcap sees a new growth driver |  |
| 10-12 | Valbiotis SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Valbiotis
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 66.56 | 44.66 | 62.05 | 23.96 | 16.42 | 22.29 | - | - |
| Change | - | -32.91% | 38.94% | -61.38% | -31.48% | 35.76% | - | - |
| Enterprise Value (EV) 1 | 52.33 | 31.01 | 43.91 | 18.1 | 12.83 | 28.49 | 36.79 | 43.49 |
| Change | - | -40.75% | 41.6% | -58.78% | -29.1% | 122.03% | 29.13% | 18.21% |
| P/E | -7.29x | -2.98x | -8.47x | -2.41x | -1.48x | -2.51x | -3.49x | -10.5x |
| PBR | 4.66x | 3.34x | 3.18x | - | - | - | - | - |
| PEG | - | -0.1x | 0.2x | -0.36x | 0.1x | 0.1x | 0.1x | 0.2x |
| Capitalization / Revenue | 24.7x | 15.9x | 9.11x | 5.16x | 15.7x | 11.1x | 3.43x | 1.42x |
| EV / Revenue | 19.4x | 11x | 6.45x | 3.9x | 12.3x | 14.2x | 5.66x | 2.77x |
| EV / EBITDA | -6.95x | -2.77x | -6.81x | -1.84x | -1.4x | -3.35x | -6.03x | -16.1x |
| EV / EBIT | -6.18x | -2.58x | -6.12x | -1.74x | -1.35x | -3.31x | -5.93x | -15.5x |
| EV / FCF | -7.01x | -3.33x | -5.43x | -1.55x | -1.57x | -3.35x | -4.43x | -6.49x |
| FCF Yield | -14.3% | -30% | -18.4% | -64.6% | -63.8% | -29.8% | -22.6% | -15.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.94 | -1.21 | -0.59 | -0.63 | -0.47 | -0.25 | -0.18 | -0.06 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.693 | 2.814 | 6.809 | 4.644 | 1.046 | 2 | 6.5 | 15.7 |
| EBITDA 1 | -7.534 | -11.17 | -6.444 | -9.836 | -9.198 | -8.5 | -6.1 | -2.7 |
| EBIT 1 | -8.475 | -12.03 | -7.18 | -10.42 | -9.494 | -8.6 | -6.2 | -2.8 |
| Net income 1 | -8.681 | -12.31 | -7.368 | -10.02 | -9.417 | -8.8 | -6.5 | -2.3 |
| Net Debt 1 | -14.23 | -13.65 | -18.14 | -5.861 | -3.586 | 6.2 | 14.5 | 21.2 |
| Reference price 2 | 6.8500 | 3.6000 | 5.0000 | 1.5200 | 0.6940 | 0.6280 | 0.6280 | 0.6280 |
| Nbr of stocks (in thousands) | 9,717 | 12,405 | 12,409 | 15,763 | 23,656 | 35,492 | - | - |
| Announcement Date | 3/15/22 | 3/15/23 | 4/26/24 | 3/3/25 | 3/2/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.6x | 14.62x | -3.44x | - | 25.72M | |
| 16.97x | 6.42x | 12.3x | 1.76% | 64.38B | |
| 30.03x | 8.21x | 26.91x | 0.04% | 56.16B | |
| 37.32x | 6.62x | 19.78x | 0.87% | 54.16B | |
| 35.94x | 3.4x | 14.66x | -.--% | 45.33B | |
| 49.01x | 5.65x | 30.93x | -.--% | 42.25B | |
| -19.75x | 191.25x | -21.04x | -.--% | 40.78B | |
| 46.05x | 8.16x | 27.33x | -.--% | 33.8B | |
| 31.61x | 8.04x | 20.91x | 0.41% | 32.25B | |
| 27.18x | 5.72x | 14.84x | -.--% | 23.57B | |
| Average | 25.18x | 25.81x | 14.32x | 0.34% | 39.27B | |
| Weighted average by Cap. | 27.79x | 25.71x | 16.39x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALVAL Stock
- Valuation Valbiotis
Select your edition
All financial news and data tailored to specific country editions
